Clinical Trial Update: MASLD Butyrate Supplementation Treatment Efficacy Review [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating butyrate supplementation for MASLD is under efficacy review; no results or status details are provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease

Drugs mentioned

• Butyrate (butyrate)

Snippet

Sponsor: University Medical Center Zvezdara | Conditions: MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease | Phase 3 | Status: UNKNOWN